We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
-10.21%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
AUM
$6.49B
AUM Growth
+$329M
Cap. Flow
+$1.05B
Cap. Flow %
16.14%
Top 10 Hldgs %
17.7%
Holding
945
New
236
Increased
167
Reduced
92
Closed
153

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$112M
2
SWKS icon
Skyworks Solutions
SWKS
+$103M
3
STM icon
STMicroelectronics
STM
+$87.3M
4
ASML icon
ASML
ASML
+$71.6M
5
PANW icon
Palo Alto Networks
PANW
+$64.4M

Sector Composition

Rank Sector Weight
1 Healthcare 34.94%
2 Technology 31.31%
3 Financials 8.29%
4 Industrials 7.52%
5 Communication Services 4.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACDC icon
526
ProFrac Holding
ACDC
$762M
$915K 0.01%
+49,999
New +$980K
EXTR icon
527
Extreme Networks
EXTR
$4.17B
$879K 0.01%
+98,509
New +$1M
ADTN icon
528
Adtran
ADTN
$719M
$853K 0.01%
+48,678
New +$881K
EPAM icon
529
EPAM Systems
EPAM
$5.68B
$853K 0.01%
+2,893
New +$884K
CTLT
530
DELISTED
CATALENT, INC.
CTLT
$844K 0.01%
+7,863
New +$801K
ANTX icon
531
AN2 Therapeutics
ANTX
$209M
$832K 0.01%
107,300
-42,700
-28% -$565K
LENZ
532
LENZ Therapeutics
LENZ
$155M
$825K 0.01%
42,862
ITQ
533
DELISTED
Itiquira Acquisition Corp. Class A Ordinary Shares
ITQ
$824K 0.01%
83,722
NGMS
534
DELISTED
NeoGames S.A. Ordinary Shares
NGMS
$806K 0.01%
60,085
+21,600
+56% +$294K
MGNX icon
535
MacroGenics
MGNX
$245M
$794K 0.01%
269,272
SEEL
536
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$788K 0.01%
302
-428
-59% -$1.11M
PRAX icon
537
Praxis Precision Medicines
PRAX
$8.7B
$756K 0.01%
20,583
WWW icon
538
Wolverine World Wide
WWW
$1.6B
$756K 0.01%
37,501
-20,346
-35% -$422K
TOAC
539
DELISTED
Talon 1 Acquisition Corp. Class A Ordinary Shares
TOAC
$755K 0.01%
75,000
CALX icon
540
Calix
CALX
$2.45B
$754K 0.01%
+22,074
New +$820K
ALTR
541
DELISTED
Altair Engineering Inc
ALTR
$751K 0.01%
+14,312
New +$782K
NETC
542
DELISTED
Nabors Energy Transition Corp.
NETC
$750K 0.01%
75,000
KAHC
543
DELISTED
KKR Acquisition Holdings I Corp.
KAHC
$734K 0.01%
75,000
PCTTW
544
PureCycle Technologies Inc Warrant
PCTTW
$10.6M
$718K 0.01%
270,831
-36,669
-12% -$116K
TPG icon
545
TPG
TPG
$7.88B
$717K 0.01%
30,000
BPAC
546
DELISTED
Bullpen Parlay Acquisition Company Class A Ordinary Share
BPAC
$694K 0.01%
70,000
QLYS icon
547
Qualys
QLYS
$5.54B
$681K 0.01%
+5,399
New +$707K
AMKR icon
548
Amkor Technology
AMKR
$13.8B
$680K 0.01%
+40,108
New +$762K
RAIN
549
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$666K 0.01%
119,700
AIRS icon
550
AirSculpt Technologies
AIRS
$351M
$662K 0.01%
+111,600
New +$1.05M

Similar funds

Woodline Partners's Q2 2022 Portfolio in Review

As of Q2 2022, Woodline Partners held 945 positions worth $6.49B, up 5.3% from $6.16B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Woodline Partners deployed $1.05B of net new capital in Q2 2022, opening 236 new positions and adding to 167 existing holdings. Its largest new stake was Skyworks Solutions: 955,660 shares worth $88.5M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 39% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Seagen Inc. Common Stock, an estimated $169M trimmed.

  • Woodline Partners's largest Q2 2022 buy was Skyworks Solutions: 955,660 shares worth $88.5M.
  • Woodline Partners added most to Eli Lilly in Q2 2022, an estimated $112M increase.
  • Woodline Partners's biggest Q2 2022 reduction was Seagen Inc. Common Stock, cutting an estimated $169M.
  • Woodline Partners fully exited Cooper Companies in Q2 2022, selling an estimated $103M.
  • Woodline Partners's ten largest holdings make up 18% of its $6.49B portfolio in Q2 2022.
  • Woodline Partners opened 236 new positions and closed 153 in Q2 2022.
  • Woodline Partners's portfolio value rose 5.3% quarter-over-quarter to $6.49B.

Based on Woodline Partners's 13F filing for Q2 2022, filed 15 Aug 2022.